{"id":"W2623888527","doi":"10.1016/s0140-6736(17)31279-5","title":"Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":556,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Etanercept; Placebo; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Clinical trial; Dermatology; Physical therapy; Gastroenterology; Tumor necrosis factor alpha; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003213419,0.000398553,0.002019948,0.00004089148,0.001112681,0.0001486445,0.0007745075,0.0003031406,0.0003320492],"category_scores_gemma":[0.004844829,0.0002225205,0.0003268719,0.00003909953,0.0003189147,0.0001342871,0.0001145568,0.0002260958,0.0001565425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007911711,"about_ca_system_score_gemma":0.0001616511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004487243,"about_ca_topic_score_gemma":0.0007290863,"domain_scores_codex":[0.9967352,0.001275393,0.0007484973,0.0005790719,0.00006957939,0.0005923251],"domain_scores_gemma":[0.9870803,0.01049535,0.0008513285,0.001456023,0.00006868075,0.00004828741],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9048159,0.00009043929,0.00001466741,0.00001232847,0.002496087,0.00001178057,0.0006730525,0.00003046333,0.02504149,0.0001198597,0.02648234,0.04021163],"study_design_scores_gemma":[0.8929906,0.0007357511,0.0001943716,0.00005990682,0.001527003,0.000008758801,0.0001253731,0.0001082772,0.024029,0.0001796223,0.07973345,0.0003078622],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9633646,0.01233816,0.0001454801,0.005302125,0.004100666,0.005014522,0.00707484,0.0001540282,0.002505563],"genre_scores_gemma":[0.9858506,0.003441098,0.0005530073,0.00009836382,0.001743963,0.000460572,0.0006888873,0.00004634455,0.007117158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05325111,"threshold_uncertainty_score":0.9074121,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1043647610923764,"score_gpt":0.3656328327658314,"score_spread":0.261268071673455,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}